MGNX Macrogenics Inc

$MGNX when your a little 250 million market cap sourounded by giants its just a matter of time you get gobbled up

$MGNX Interesting r/r here in light of the B7-H3 conjugates interest across BP. Daiichi/Merck, GSK and Roche pursuing SCLC, Biontech is going for Prostate and MGNX for SCCHN, Endometrial, Melanoma, Sarcoma.

$MGNX Positive HC Wainwright conference call/update this am. CEOsounds very excited to give the ESMO update.

$MGNX many shots on goal, excellent history of producing marketed drugs, strong balance sheet,2.3 billion in "bonus bucks" New CEO with a laser focus on creating shareholder value. overall a compelling investment opportunity.

$MGNX - take a look at the ties with the phase 3 trial of Taishan-302 success. Possible runner Monday AM.

$MGNX anyone has one decent reason for yesterdays bid and today trashing on no volumen?

$MGNX If you can find the time, I would be curious to see an infographic of say the 50-100 of biotech companies doing TCE.

$MGNX kind of annoying that this drives down into the basement and then they can clean up the technicals on a crap day.

$MGNX bod should be fired and company liquidated….best value proposition for investors right now 😂😂😂🤷‍♂️

$MGNX working on a new app that should be launching in the next 60 days. Heavy focus on biotech. Here is what it picked up overnight that I read in my morning brief.

$MGNX Agree. $MGNX is a little late to the B7-H3 party but the efficacy we've seen is amazing. B7-H3 is proving to be a great target. It's nice B7-H3 is broadly expressed in many cancers so $MGNX should be able to find a few niches to stand out in.

$MGNX as long as we can not avoid these low volume drops, we can not really move higher... waiting game continues